$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$147.35M
Market Cap
-
P/E Ratio
-1.06
EPS
$3.40
52 Week High
$0.87
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Alector, Inc. (ALEC) is a leading clinical-stage biopharmaceutical firm focused on creating breakthrough therapies for neurodegenerative diseases such as Alzheimer's and frontotemporal dementia. The company harnesses its innovative immuno-neurology platform to engage the immune system in revitalizing neuronal health and function. Headquartered in South San Francisco, Alector is committed to advancing the treatment landscape within neurology, showcased by a robust pipeline of differentiated product candidates that hold the potential to significantly alter the course of these challenging conditions.
LPTX
VHAI
KTTA
BITF
IPG
ADAP
AMD
TLRY
BIYA
BYND
MTSR
ITUB
NVDA
INTC
APLD
CLSK
SNAP
ADTX
KSS
KDLY
ASST
SAND
SHOT
ZAPP
NBIS
CIFR
NEHC
PLUG
NIO
IREN
MPW
WULF
WFC
GOOGL
MARA
TSLA
IBRX
FL
CPRT
FI
AG
VGFC
NEM
WU
UAA
AGL
CX
TMC
TGI
FNGB
ABVE
FRO
SOFI
F
ZI
TRVI
DE
NVTS
MAT
DVLT
OMGA
LPTX
VHAI
KTTA
BITF
IPG
ADAP
AMD
TLRY
BIYA
BYND
MTSR
ITUB
NVDA
INTC
APLD
CLSK
SNAP
ADTX
KSS
KDLY
ASST
SAND
SHOT
ZAPP
NBIS
CIFR
NEHC
PLUG
NIO
IREN
MPW
WULF
WFC
GOOGL
MARA
TSLA
IBRX
FL
CPRT
FI
AG
VGFC
NEM
WU
UAA
AGL
CX
TMC
TGI
FNGB
ABVE
FRO
SOFI
F
ZI
TRVI
DE
NVTS
MAT
DVLT
OMGA